We offer you a comprehensive package of highly specialized disease models and drug efficacy testing services ranging from our unique in vitro efficacy assays to cancer animal models and analytical services for early drug development. Our focus is on translational disease models, orthotopic animal models and syngeneic cancer models . We specialize in providing efficacy testing services for diseases with unmet clinical needs, such as cancer metastasis.

Special emphasis is placed on the high clinical predictivity the data acquired with our models. This translates to significantly lower efficacy-related failure rates in the later stages of drug development. We can also help you test your new drug candidates for possible adverse effects on or assist you in obtaining FDA approval (regulatory study) for your osteoporosis drug candidate.

Please browse the menu on the left for additional information on our individual services, or contact us for further details on pricing, etc. Below you can find out how our services can benefit the various stages of your drug development. Please roll your mouse over the various steps to obtain further information.

For additional information please contact:

Real-life case studies: